MORROW Targets US$230 Million Annual Revenue as Singapore Flagship Launches

0
MORROW Targets US$230 Million Annual Revenue as Singapore Flagship Launches
MORROW Targets US$230 Million Annual Revenue as Singapore Flagship Launches

The 45,000 sq ft Singapore flagship marks MORROW’s first proof point of its globally scalable model designed to make preventive healthcare accessible to the many, rather than a luxury for the few.

SINGAPORE – is a longevity platform founded in Singapore by entrepreneur and investor Allen Law. Built on the idea that health should be continuous rather than reactive, MORROW brings diagnostics, medical oversight, coaching, movement, recovery, nutrition, and lifestyle support into a single integrated environment.

Its 45,000 sq ft Singapore flagship, backed by US$156 million in committed investment, is designed as the first proof point for a model of preventive health that can be scaled across major cities.

About Allen Law
is an entrepreneur and investor focused on building systems that help people live longer, healthier lives. His mission is to make longevity accessible at scale by accelerating the global transition from reactive healthcare to preventive healthcare.

He is the Founder and CEO of and Principal at , a venture platform backing companies across health, movement, wellness, diagnostics and human performance. He is also the founder of and , two internationally recognised wellness and fitness brands, and previously built from a single hotel into an international hospitality business.

Drawing on a track record of building and scaling businesses across hospitality, wellness and fitness, Law is now applying the same systems-thinking to longevity. Through MORROW, he is building the physical and operating infrastructure that enables continuous health management, early intervention and science-led longevity care to become part of everyday life.

His set out his vision for the future of preventive healthcare and the infrastructure required to support the Longevity Century.